Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)

Background: The incidence of acute rhinosinusitis (ARS) is high throughout the world. Although diagnosis is clinical and disease course is mostly self-limiting, diagnostic tools and medications are overused by physicians, thus increasing the direct medical costs of the disease. Objective: The aim of...

ver descrição completa

Detalhes bibliográficos
Autores: Jaume, F., Alobid, I, Mullol, J., Quinto, L.
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/19543
Acesso em linha:https://hdl.handle.net/20.500.13003/19543
Access Level:acceso abierto
Palavra-chave:Sinusitis
Nasal Polyps
Prospective Studies
Spain
Humans
Rhinitis
Humanos
Estudios Prospectivos
Rinitis
Pólipos Nasales
España
Acute rhinosinusitis
Common cold
EPOS
Direct costs
PROSINUS
id ES_d359fd54373b4e2c2c401a115b8d46c3
oai_identifier_str oai:docusalut.com:20.500.13003/19543
network_acronym_str ES
network_name_str España
repository_id_str
spelling Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)Jaume, F.Alobid, IMullol, J.Quinto, L.SinusitisNasal PolypsProspective StudiesSpainHumansRhinitisHumanosEstudios ProspectivosSinusitisRinitisPólipos NasalesEspañaAcute rhinosinusitisCommon coldEPOSDirect costsPROSINUSBackground: The incidence of acute rhinosinusitis (ARS) is high throughout the world. Although diagnosis is clinical and disease course is mostly self-limiting, diagnostic tools and medications are overused by physicians, thus increasing the direct medical costs of the disease. Objective: The aim of the PROSINUS study was to quantify the direct medical costs of management of ARS in Spain. Methods: We performed a prospective observational study of 1610 patients with a clinical diagnosis of nonbacterial, uncomplicated ARS. According to the duration of symptoms by the European Position Paper on Rhinosinusitis and Nasal Polyps, patients were classified as having viral or postviral ARS with different levels of severity. Direct medical costs were calculated based on medical visits, use of diagnostic tools, and medications prescribed. Results: Overall, the mean (SD) direct medical costs per episode were euro322.3 (301.2) vs euro441.1 (344.3) for viral and postviral ARS episodes, respectively (P<.001). When viral and postviral disease were compared, the medical costs per episode were euro245.0 (265.4) vs euro328.4 (301.9) for medical visits (P<.001), euro38.1 (64.0) vs euro61.9 (78.8) for diagnostic tools (P<.001), and euro39.2 (25.9) vs euro50.8 (25.3) Conclusions: The direct medical costs of postviral ARS episodes were higher than those of viral episodes (common cold). Uncomplicated nonbacterial ARS represents an important socioeconomic burden owing to the excessive number of medical visits, use of diagnostic tools, and medications prescribed.Esmon Publicidad S A, Dept Allergy & Clin Immunol, Clin Univ Navarra20212021-01-0120212021-01-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.13003/19543reponame:Docusalutinstname:Conselleria de Salut i Consum del Govern de les Illes BalearsInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docusalut.com:20.500.13003/195432026-06-22T12:44:07Z
dc.title.none.fl_str_mv Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
title Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
spellingShingle Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
Jaume, F.
Sinusitis
Nasal Polyps
Prospective Studies
Spain
Humans
Rhinitis
Humanos
Estudios Prospectivos
Sinusitis
Rinitis
Pólipos Nasales
España
Acute rhinosinusitis
Common cold
EPOS
Direct costs
PROSINUS
title_short Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
title_full Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
title_fullStr Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
title_full_unstemmed Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
title_sort Direct Costs of Acute Rhinosinusitis in Spain: A Prospective and Observational Study (PROSINUS)
dc.creator.none.fl_str_mv Jaume, F.
Alobid, I
Mullol, J.
Quinto, L.
author Jaume, F.
author_facet Jaume, F.
Alobid, I
Mullol, J.
Quinto, L.
author_role author
author2 Alobid, I
Mullol, J.
Quinto, L.
author2_role author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Sinusitis
Nasal Polyps
Prospective Studies
Spain
Humans
Rhinitis
Humanos
Estudios Prospectivos
Sinusitis
Rinitis
Pólipos Nasales
España
Acute rhinosinusitis
Common cold
EPOS
Direct costs
PROSINUS
topic Sinusitis
Nasal Polyps
Prospective Studies
Spain
Humans
Rhinitis
Humanos
Estudios Prospectivos
Sinusitis
Rinitis
Pólipos Nasales
España
Acute rhinosinusitis
Common cold
EPOS
Direct costs
PROSINUS
description Background: The incidence of acute rhinosinusitis (ARS) is high throughout the world. Although diagnosis is clinical and disease course is mostly self-limiting, diagnostic tools and medications are overused by physicians, thus increasing the direct medical costs of the disease. Objective: The aim of the PROSINUS study was to quantify the direct medical costs of management of ARS in Spain. Methods: We performed a prospective observational study of 1610 patients with a clinical diagnosis of nonbacterial, uncomplicated ARS. According to the duration of symptoms by the European Position Paper on Rhinosinusitis and Nasal Polyps, patients were classified as having viral or postviral ARS with different levels of severity. Direct medical costs were calculated based on medical visits, use of diagnostic tools, and medications prescribed. Results: Overall, the mean (SD) direct medical costs per episode were euro322.3 (301.2) vs euro441.1 (344.3) for viral and postviral ARS episodes, respectively (P<.001). When viral and postviral disease were compared, the medical costs per episode were euro245.0 (265.4) vs euro328.4 (301.9) for medical visits (P<.001), euro38.1 (64.0) vs euro61.9 (78.8) for diagnostic tools (P<.001), and euro39.2 (25.9) vs euro50.8 (25.3) Conclusions: The direct medical costs of postviral ARS episodes were higher than those of viral episodes (common cold). Uncomplicated nonbacterial ARS represents an important socioeconomic burden owing to the excessive number of medical visits, use of diagnostic tools, and medications prescribed.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01
2021
2021-01-01
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.13003/19543
url https://hdl.handle.net/20.500.13003/19543
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Esmon Publicidad S A, Dept Allergy & Clin Immunol, Clin Univ Navarra
publisher.none.fl_str_mv Esmon Publicidad S A, Dept Allergy & Clin Immunol, Clin Univ Navarra
dc.source.none.fl_str_mv reponame:Docusalut
instname:Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
reponame_str Docusalut
collection Docusalut
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420452397449216
score 15,81155

Registos relacionados